300 related articles for article (PubMed ID: 21256601)
1. Immune reconstitution of the female reproductive tract of humanized BLT mice and their susceptibility to human immunodeficiency virus infection.
Olesen R; Wahl A; Denton PW; Garcia JV
J Reprod Immunol; 2011 Mar; 88(2):195-203. PubMed ID: 21256601
[TBL] [Abstract][Full Text] [Related]
2. Antiretroviral pre-exposure prophylaxis prevents vaginal transmission of HIV-1 in humanized BLT mice.
Denton PW; Estes JD; Sun Z; Othieno FA; Wei BL; Wege AK; Powell DA; Payne D; Haase AT; Garcia JV
PLoS Med; 2008 Jan; 5(1):e16. PubMed ID: 18198941
[TBL] [Abstract][Full Text] [Related]
3. BLT humanized mice as model to study HIV vaginal transmission.
Deruaz M; Luster AD
J Infect Dis; 2013 Nov; 208 Suppl 2(Suppl 2):S131-6. PubMed ID: 24151319
[TBL] [Abstract][Full Text] [Related]
4. One percent tenofovir applied topically to humanized BLT mice and used according to the CAPRISA 004 experimental design demonstrates partial protection from vaginal HIV infection, validating the BLT model for evaluation of new microbicide candidates.
Denton PW; Othieno F; Martinez-Torres F; Zou W; Krisko JF; Fleming E; Zein S; Powell DA; Wahl A; Kwak YT; Welch BD; Kay MS; Payne DA; Gallay P; Appella E; Estes JD; Lu M; Garcia JV
J Virol; 2011 Aug; 85(15):7582-93. PubMed ID: 21593172
[TBL] [Abstract][Full Text] [Related]
5. Mucosal transmission of R5 and X4 tropic HIV-1 via vaginal and rectal routes in humanized Rag2-/- gammac -/- (RAG-hu) mice.
Berges BK; Akkina SR; Folkvord JM; Connick E; Akkina R
Virology; 2008 Apr; 373(2):342-51. PubMed ID: 18207484
[TBL] [Abstract][Full Text] [Related]
6. A long-acting formulation of the integrase inhibitor raltegravir protects humanized BLT mice from repeated high-dose vaginal HIV challenges.
Kovarova M; Swanson MD; Sanchez RI; Baker CE; Steve J; Spagnuolo RA; Howell BJ; Hazuda DJ; Garcia JV
J Antimicrob Chemother; 2016 Jun; 71(6):1586-96. PubMed ID: 27002074
[TBL] [Abstract][Full Text] [Related]
7. A Caulobacter crescentus Microbicide Protects from Vaginal Infection with HIV-1
Farr Zuend C; Nomellini JF; Smit J; Horwitz MS
J Virol; 2019 Sep; 93(18):. PubMed ID: 31243127
[TBL] [Abstract][Full Text] [Related]
8. BLT humanized mice as a small animal model of HIV infection.
Karpel ME; Boutwell CL; Allen TM
Curr Opin Virol; 2015 Aug; 13():75-80. PubMed ID: 26083316
[TBL] [Abstract][Full Text] [Related]
9. Immunization of BLT Humanized Mice Redirects T Cell Responses to Gag and Reduces Acute HIV-1 Viremia.
Claiborne DT; Dudek TE; Maldini CR; Power KA; Ghebremichael M; Seung E; Mellors EF; Vrbanac VD; Krupp K; Bisesi A; Tager AM; Knipe DM; Boutwell CL; Allen TM
J Virol; 2019 Oct; 93(20):. PubMed ID: 31375576
[TBL] [Abstract][Full Text] [Related]
10. Superior human leukocyte reconstitution and susceptibility to vaginal HIV transmission in humanized NOD-scid IL-2Rγ(-/-) (NSG) BLT mice.
Stoddart CA; Maidji E; Galkina SA; Kosikova G; Rivera JM; Moreno ME; Sloan B; Joshi P; Long BR
Virology; 2011 Aug; 417(1):154-60. PubMed ID: 21684569
[TBL] [Abstract][Full Text] [Related]
11. Modeling HIV-1 Mucosal Transmission and Prevention in Humanized Mice.
Veselinovic M; Charlins P; Akkina R
Methods Mol Biol; 2016; 1354():203-20. PubMed ID: 26714714
[TBL] [Abstract][Full Text] [Related]
12. The utility of the new generation of humanized mice to study HIV-1 infection: transmission, prevention, pathogenesis, and treatment.
Berges BK; Rowan MR
Retrovirology; 2011 Aug; 8():65. PubMed ID: 21835012
[TBL] [Abstract][Full Text] [Related]
13. Systemic administration of antiretrovirals prior to exposure prevents rectal and intravenous HIV-1 transmission in humanized BLT mice.
Denton PW; Krisko JF; Powell DA; Mathias M; Kwak YT; Martinez-Torres F; Zou W; Payne DA; Estes JD; Garcia JV
PLoS One; 2010 Jan; 5(1):e8829. PubMed ID: 20098623
[TBL] [Abstract][Full Text] [Related]
14. Perspectives on Non-BLT Humanized Mouse Models for Studying HIV Pathogenesis and Therapy.
Terahara K; Iwabuchi R; Tsunetsugu-Yokota Y
Viruses; 2021 Apr; 13(5):. PubMed ID: 33924786
[TBL] [Abstract][Full Text] [Related]
15. HIV pre-exposure prophylaxis for women and infants prevents vaginal and oral HIV transmission in a preclinical model of HIV infection.
Kovarova M; Shanmugasundaram U; Baker CE; Spagnuolo RA; De C; Nixon CC; Wahl A; Garcia JV
J Antimicrob Chemother; 2016 Nov; 71(11):3185-3194. PubMed ID: 27494916
[TBL] [Abstract][Full Text] [Related]
16. Humanized Mouse Models for Human Immunodeficiency Virus Infection.
Marsden MD; Zack JA
Annu Rev Virol; 2017 Sep; 4(1):393-412. PubMed ID: 28746819
[TBL] [Abstract][Full Text] [Related]
17. Alpha interferon and HIV infection cause activation of human T cells in NSG-BLT mice.
Long BR; Stoddart CA
J Virol; 2012 Mar; 86(6):3327-36. PubMed ID: 22238321
[TBL] [Abstract][Full Text] [Related]
18. The Vaginal Acquisition and Dissemination of HIV-1 Infection in a Novel Transgenic Mouse Model Is Facilitated by Coinfection with Herpes Simplex Virus 2 and Is Inhibited by Microbicide Treatment.
Seay K; Khajoueinejad N; Zheng JH; Kiser P; Ochsenbauer C; Kappes JC; Herold B; Goldstein H
J Virol; 2015 Sep; 89(18):9559-70. PubMed ID: 26157126
[TBL] [Abstract][Full Text] [Related]
19. HIV-specific CD8⁺ T-cell immunity in humanized bone marrow-liver-thymus mice.
Dudek TE; Allen TM
J Infect Dis; 2013 Nov; 208 Suppl 2(Suppl 2):S150-4. PubMed ID: 24151322
[TBL] [Abstract][Full Text] [Related]
20. Humanized mouse models of HIV infection.
Denton PW; García JV
AIDS Rev; 2011; 13(3):135-48. PubMed ID: 21799532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
